QuantuMDx is an member of the Stop TB Partnership Private Sector Constituency (PSC) and on World TB Day (24th March), we’re coming together to highlight the devastating health, social, and
This month we find out more about Nerea Plaza and her role as a Mechanical Engineer at QuantuMDx. When did you know you wanted to be a engineer and
To coincide with Cervical Cancer Prevention Week, QuantuMDx Group has announced the start of a field study with St George’s, University of London, to evaluate its human papilloma virus (HPV)
To mark the start of Cervical Cancer Prevention Week, we’ve devised an infographic to outline the burden of cervical cancer in low and middle income countries and highlight the need
QuantuMDx Group Limited and Molbio Diagnostics Private Limited have signed a memorandum of understanding (MoU) to explore opportunities for joint working in infectious disease diagnostics, with an initial focus
Under the spotlight this month it’s Jonathan Peat, VP Business Development, giving us an insight into his role and career highlights. When did you know you wanted to be
In February last year we announced a partnership with Intellectual Ventures’ Global Good fund, to develop a test to support cervical cancer screening in low- and middle-income countries (LMICs). We are jointly developing
Next week, world leaders will meet to take part in the first UN High Level Meeting on TB, in history. As QuantuMDx is the only UK company accredited to attend
QuantuMDx Group Ltd today announced two key leadership appointments. Dr Allan Brown has been appointed Chief Operating Officer and David Matthews joins as Chief Financial Officer. “These appointments represent the
To celebrate our 10th birthday this year, we’ve produced an infographic to chart our incredible journey, from a makeshift laboratory in a Sussex garage, to performance testing of our Q-POC™
